Clinical Trial Update: Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study [Phase 3]

View source ↗

Summary

Phase 3 confirmation study of inhaled iloprost (Ventavis) evaluating efficacy, safety, and pharmacokinetics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 3 | Status: COMPLETED